• Local contact QPPV (Bulgaria and Romania) and related Pharmacovigilance services to support Marketing Authorisation Holders (MAH) for achieving compliance with EU regulatory requirements (Regulation 1235/2010 and Directive 2010/84/EC) and local obligations to assign a local point of contact for pharmacovigilance for every registered product in the country.
  • Literature screening and follow-up assessment of relevant articles/scientific extracts. Medical review of cases in literature can help you identify important signals concerning the safety profile of your products.
  •  

    If you wish to report an adverse event, please use our "Contact Us" form. Thank you. We will revert to you as soon as possible.